Ezurpimtrostat (GNS561) is an orally active PPT1 inhibitor, autophagy inhibitor, immunomodulator, anti-inflammatory agent, and anticancer agent. Ezurpimtrostat inhibits PPT1, dysregulates lysosomal function, redistributes mTOR, and induces apoptosis. Ezurpimtrostat reduces IFN-alpha, CRP, immune complex deposition, and SARS-CoV-2 viral load. Ezurpimtrostat can be used for the study of systemic lupus erythematosus, SARS-CoV-2, hepatocellular carcinoma, fibrosis, and related disorders[1][2][3][4].
Molekulargewicht:
422.99
Reinheit:
99.37
CAS Nummer:
[1914148-72-3]
Formel:
C25H31ClN4
Target-Kategorie:
Apoptosis,Autophagy,IFNAR,SARS-CoV
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten